Systemic Radiotherapy with Monoclonal Antibodies : Options and Problems /
| Main Author: | |
|---|---|
| Corporate Author: | |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg,
1996.
|
| Series: | Recent results in cancer research ;
141. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- High dose radioimmunotherapy in malignant lymphoma
- Treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates
- Two approaches for enhancing radioimmunotherapy: emitters and hyperthermia
- Use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant tratment of patients with high grade gliomas of the brain, treatment of diffuse leptomeningeal malignanca by intrathecal injection of 131I-radioimmunoconjugates
- Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibodies (Fab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice
- Problems and advances in the dosimetry of radionuclide targeted therapy
- Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiation
- Monoclonal antibodies in tumor therapy
- Use of radioimmunotherapy in combination with bioreductive agents
- Optimal therapeutic strategies for radioimmunotherapy
- Minimal residual disease
- Can preirradiation enhance tumor uptake of radiolabled pharmaceuticals?